| Use of CAR-transduced natural killer cells in CD19-positive lymphoid tumors E Liu, D Marin, P Banerjee, HA Macapinlac, P Thompson, R Basar, ... New England Journal of Medicine 382 (6), 545-553, 2020 | 1514 | 2020 |
| First-and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation PJ Martin, JD Rizzo, JR Wingard, K Ballen, PT Curtin, C Cutler, MR Litzow, ... Biology of Blood and Marrow Transplantation 18 (8), 1150-1163, 2012 | 707 | 2012 |
| Cord-blood engraftment with ex vivo mesenchymal-cell coculture M De Lima, I McNiece, SN Robinson, M Munsell, M Eapen, M Horowitz, ... New England Journal of Medicine 367 (24), 2305-2315, 2012 | 535 | 2012 |
| Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells P Kebriaei, H Singh, MH Huls, MJ Figliola, R Bassett, S Olivares, B Jena, ... The Journal of clinical investigation 126 (9), 3363-3376, 2016 | 520 | 2016 |
| Transplantation of ex vivo expanded cord blood EJ Shpall, R Quinones, R Giller, C Zeng, AE Baron, RB Jones, ... Biology of Blood and Marrow Transplantation 8 (7), 368-376, 2002 | 503 | 2002 |
| Double hit lymphoma: the MD A nderson C ancer C enter clinical experience Y Oki, M Noorani, P Lin, RE Davis, SS Neelapu, L Ma, M Ahmed, ... British journal of haematology 166 (6), 891-901, 2014 | 409 | 2014 |
| Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation SO Ciurea, V Mulanovich, RM Saliba, UD Bayraktar, Y Jiang, R Bassett, ... Biology of Blood and Marrow Transplantation 18 (12), 1835-1844, 2012 | 288 | 2012 |
| Prognostic value of nodal ratios in node-positive breast cancer WA Woodward, V Vinh-Hung, NT Ueno, YC Cheng, M Royce, P Tai, ... Journal of Clinical Oncology 24 (18), 2910-2916, 2006 | 231 | 2006 |
| Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma U Popat, R Saliba, R Thandi, C Hosing, M Qazilbash, P Anderlini, ... Biology of Blood and Marrow Transplantation 15 (6), 718-723, 2009 | 193 | 2009 |
| Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer I McNiece, R Jones, SI Bearman, P Cagnoni, Y Nieto, W Franklin, J Ryder, ... Blood, The Journal of the American Society of Hematology 96 (9), 3001-3007, 2000 | 188 | 2000 |
| Phase I study of cord blood‐derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma N Shah, L Li, J McCarty, I Kaur, E Yvon, H Shaim, M Muftuoglu, E Liu, ... British journal of haematology 177 (3), 457-466, 2017 | 178 | 2017 |
| PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation P Armand, YB Chen, RA Redd, RM Joyce, J Bsat, E Jeter, RW Merryman, ... Blood, The Journal of the American Society of Hematology 134 (1), 22-29, 2019 | 159 | 2019 |
| Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation U Popat, RS Mehta, K Rezvani, P Fox, K Kondo, D Marin, I McNiece, ... Blood, The Journal of the American Society of Hematology 125 (19), 2885-2892, 2015 | 148 | 2015 |
| Prognostic model for relapse after high-dose chemotherapy with autologous stem-cell transplantation for stage IV oligometastatic breast cancer Y Nieto, S Nawaz, RB Jones, EJ Shpall, PJ Cagnoni, PA McSweeney, ... Journal of clinical oncology 20 (3), 707-718, 2002 | 141 | 2002 |
| Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma CC Pinnix, GL Smith, S Milgrom, EM Osborne, JP Reddy, M Akhtari, ... International Journal of Radiation Oncology* Biology* Physics 92 (1), 175-182, 2015 | 140 | 2015 |
| Prognostic significance of overexpression and phosphorylation of epidermal growth factor receptor (EGFR) and the presence of truncated EGFRvIII in locoregionally advanced … Y Nieto, F Nawaz, RB Jones, EJ Shpall, S Nawaz Journal of clinical oncology 25 (28), 4405-4413, 2007 | 114 | 2007 |
| Myeloablative reduced-toxicity iv busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in … G Alatrash, M De Lima, N Hamerschlak, M Pelosini, X Wang, L Xiao, ... Biology of Blood and Marrow Transplantation 17 (10), 1490-1496, 2011 | 105 | 2011 |
| The survival outcome of patients with relapsed/refractory peripheral T‐cell lymphoma‐not otherwise specified and angioimmunoblastic T‐cell lymphoma D Chihara, MA Fanale, RN Miranda, M Noorani, JR Westin, LJ Nastoupil, ... British journal of haematology 176 (5), 750-758, 2017 | 102 | 2017 |
| Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution C Hosing, R Bassett, B Dabaja, R Talpur, A Alousi, S Ciurea, U Popat, ... Annals of Oncology 26 (12), 2490-2495, 2015 | 102 | 2015 |
| Clarifying busulfan metabolism and drug interactions to support new therapeutic drug monitoring strategies: a comprehensive review AL Myers, JD Kawedia, RE Champlin, MA Kramer, Y Nieto, R Ghose, ... Expert opinion on drug metabolism & toxicology 13 (9), 901-923, 2017 | 99 | 2017 |
